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Abstract
Background: Integrin-linked kinase (ILK) is a widely conserved serine/threonine kinase that regulates diverse signal
transduction pathways implicated in cardiac hypertrophy and contractility. In this study we explored whether experimental
overexpression of ILK would up-regulate morphogenesis in the human fetal heart.
Methodology/Principal Findings: Primary cultures of human fetal myocardial cells (19–22 weeks gestation) yielded
scattered aggregates of cardioblasts positive for the early cardiac lineage marker nk62.5 and containing nascent
sarcomeres. Cardiac cells in colonies uniformly expressed the gap junction protein connexin 43 (C643) and displayed a
spectrum of differentiation with only a subset of cells exhibiting the late cardiomyogenic marker troponin T (cTnT) and
evidence of electrical excitability. Adenovirus-mediated overexpression of ILK potently increased the number of new
aggregates of primitive cardioblasts (p,0.001). The number of cardioblast colonies was significantly decreased (p,0.05)
when ILK expression was knocked down with ILK targeted siRNA. Interestingly, overexpression of the activation resistant ILK
mutant (ILK
R211A) resulted in much greater increase in the number of new cell aggregates as compared to overexpression of
wild-type ILK (ILK
WT). The cardiomyogenic effects of ILK
R211A and ILK
WT were accompanied by concurrent activation of b-
catenin (p,0.001) and increase expression of progenitor cell marker islet-1, which was also observed in lysates of transgenic
mice with cardiac-specific over-expression of ILK
R211A and ILK
WT. Finally, endogenous ILK expression was shown to increase
in concert with those of cardiomyogenic markers during directed cardiomyogenic differentiation in human embryonic stem
cells (hESCs).
Conclusions/Significance: In the human fetal heart ILK activation is instructive to the specification of mesodermal precursor
cells towards a cardiomyogenic lineage. Induction of cardiomyogenesis by ILK overexpression bypasses the requirement of
proximal PI3K activation for transduction of growth factor- and b1-integrin-mediated differentiation signals. Altogether, our
data indicate that ILK represents a novel regulatory checkpoint during human cardiomyogenesis.
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Introduction
Integrin-linked kinase (ILK) is a multidomain integrin adaptor
protein that possesses widely conserved structural and signal
transduction functions [1,2]. ILK binds to cytoplasmic domains of
ß1-, ß2-, and ß3-integrin subunits and nucleates a supramolecular
complex at the site of focal adhesions that connects to the actin
cytoskeleton, thereby linking the extracellular matrix to the
cytoskeleton in a manner essential for bidirectional force transduc-
tion [2]. Adaptor complexes centered around ILK comprise a
signaling platform that, in response to distinct signal inputs from
integrins and growth factor receptor tyrosine kinases, activates
signaling pathwaysregulatinggrowth,survival,cellcycleprogression,
epithelial-mesenchymal transition, and cellular differentiation [1,3].
In the postnatal heart, ILK serves dual function as a
mechanoreceptor and as a nodal regulator of adaptive, prohyper-
trophic signaling [4–6]. ILK-deficient mice die early during
embryonic development owing to defects in epiblast polarization
with an abnormal distribution of F-actin [7]. Specific localization
of ILK to costameric and Z-disc structures implies a functional
role in the integration of cardiac mechanoreception and contrac-
tility [8]. Disruption of ILK kinase activity results in heart failure
phenotype in zebrafish that is dependent upon ILK-mediated
vascular endothelial growth factor signaling (VEGF) [9]. Condi-
tional ILK deletion in the mouse heart causes spontaneous dilated
cardiomyopathy and sudden death at 6 to 12 weeks of age [10],
suggesting an important and distinct role of ILK during vertebrate
cardiac morphogenesis.
ILK activation by growth factor stimulation is normally
regulated in a phosphoinositide 3-kinase (PI3K)-dependent
manner involving activation of ILK by phosphatidylinositol
(3,4,5)-trisphosphate (PIP3), which interacts with the central
pleckstrin homology (PH)-like domain of ILK [11]. ILK signaling
induces downstream phosphorylation of Akt/PKB on Ser473 and
glycogen synthase-3b (GSK-3b) on Ser9, providing a molecular
basis for its prosurvival, prohypertrophic effects [4,5,10].
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and upon exposure to hypoxia, activates endothelial cell (EC)
expression of hypoxia inducible factor 1-a (HIF1-a) and VEGF;
in turn, receptor tyrosine kinase activation by VEGF stimulates
HIF-1a in an amplification loop involving PI3K and ILK
activation [12]. ILK was revealed as an upstream regulator of
the EC hypoxic stress response that controls the recruitment of
endothelial progenitor cells to ischemic tissue [13].
ILK regulates the Wnt signaling pathway to stimulate b-
catenin/T cell factor (Tcf) transcriptional activity through negative
regulation of GSK-3b [3]. Chemical inhibitors of GSK-3b and
activation of b-catenin promote expansion of embryonic and
postnatal Islet-1 (Isl1) cardiac progenitor cells [14]. Tcf3 acts as a
cell-intrinsic inhibitor of pluripotent cell self-renewal through
repressive binding to the Oct4 promoter, so that ILK-mediated
activation of the Tcf3 transcriptional complex would be predicted
to favor cellular differentiation [15,16]. Activation of the Wnt/b-
catenin pathway promotes cardiogenesis in early phase mouse ES
cells [17]. Together, these data support the hypothesis that ILK
pathway activation promotes cardiomyogenesis in susceptible
precardiomyogenic progenitor cells.
The results of this study identify ILK as a novel cardiotropic
factor that promotes recruitment of human fetal heart cells to a
cardiomyogenic fate.
Results
Adenoviral-mediated Overexpression of ILK in Cultures of
Cells Isolated from Human Fetal Myocardium Enhances
the Formation of Aggregates of Cardioblasts
Initial immuno-histochemical screening demonstrated that the
majority of cells isolated from human fetal myocardium (19–22
weeks gestation) were positive for vimentin, a specific maker for
mesenchymal cells that is also expressed in fibroblasts, endothelial
cells and myocytes at very early differentiation stage [18].
Approximately 35% of cells were positive for the early cardiac
lineage marker nk62.5, and ,20% of cells were positive for
muscle marker a-actin and cardiomyocyte-specific sarcomeric
protein ß-myosin heavy chain (ß-MHC) and were Ki-67 positive
(Figure 1A). Less than 5% of isolated cells demonstrated the
presence of smooth muscle cell a-actin (data not shown). Electron
microscopy (EM) showed that cardioblasts contained nascent
sacromeric structures (Figure 1B). Many of these cells exhibited
with a tight connection with extracellular collagen fibers (in some
cases filling their invaginations) that were likely produced before
their cardiomyogenic commitment (Figure 1B).
Freshly isolated cells were pre-incubated for 2 h and then the
non-adherent fraction was separated from the adherent fraction of
myocardial cells. Characterization of cells was performed within 7
days, with or without infection, following separation of cell
fractions. We show by immunostaining and by EM that non-
adherent cells were enriched with uniform aggregates of immature
ß-MHC-positive cardioblasts (Figure 1C). These cellular aggre-
gates were identical to those present among unfractioned cells and
contain poorly organized sarcomeres adjacent to abundant clusters
of mitochondria (Figure 1B). Only a small subset of cardioblasts
expressed the late sarcomeric marker cardiac troponin T (cTnT)
(Figure 1D). The fraction of initially floating and aggregating cells
attached to the bottom of the culture dishes within 24 h of
incubation. In contrast, the initially adherent cells were uniformly
spread and did not aggregate (Figure 1C). This phenotypically
diversified fraction of adherent cells contained fibroblasts, smooth
muscle cells, endothelial cells and a subset of non-differentiated
mesodermal cells. Interestingly, the adherent cellular fraction is
typically depleted in many studies by pre-plating cells for the
purpose of yielding cardiomyocyte-enriched cultures [19]. How-
ever, our studies described below reveal the adherent fraction to be
a source of cells capable of differentiation into a cardiomyogenic
phenotype.
To determine the effects of ILK overexpression on cardiomyo-
genic morphogenesis, both adherent and non-adherent cells were
transduced with adenovirus encoding a cDNA for either human
wild type ILK-GFP (ad-ILK
WT) or empty adenoviral GFP control
(ad-GFP). We found, that 4 days after transduction, ,80% of cells
expressed GFP in both adherent and initially non-adherent
fractions of myocardium-derived cells indicating high efficiency
of transduction (Figure 2A). The ad-ILK
WT transduced cultures
yielded numerous spherical aggregates, representing about 2 fold
increase compared to non-transduced control cultures and to
cultures transduced with the empty vector alone (p,0.001)
(Figure 2B). Moreover, ad-ILK
WT induced aggregates were
comprised of GFP positive cells, whereas the sparse aggregates
in the control groups did not show conspicuous GFP staining. The
increased levels of ILK protein expression in ad-ILK
WT cultures
were confirmed by Western blot analysis (Figure 2C).
ILK Overexpression Bypasses the Requirement for
Exogenous Growth Factor-mediated PI3K Activation in
the Induction of Cardiomyogenesis
To test the requirement for PI3K activation in the ILK-
mediated cardiomyogenic effect, we also employed overexpression
of a mutant ILK gene deficient in PIP3 binding as a result of a
point mutation in its PH domain (ILK
R211A) [4,20]. ILK
R211A
treated cultures demonstrated higher levels of ILK protein
expression (,3-fold increase) as compared to ad-ILK
WT infected
cultures (Figure 2C). Ad-ILK
R211A treatment also resulted in
significant increase in the number of cellular aggregates, detected
in both the initially adherent as well as non-adherent cardiac cell
populations (Figure 2B). The finding that the cardiomyogenic
effects of WT ILK overexpression were evident in non-adherent
and adherent fractions, and the corresponding enhanced response
to the ILK R211A mutation (p,0.03, ILK
WT vs. ILK
R211A (NAC);
p,0.001, ILK
WT vs. ILK
R211A (AC)), indicate that exogenously
delivered ILK (WT and R211A) acts cell-autonomously to bypass
the requirement for PI3K-dependent activation to transduce
survival and differentiation signals.
Endogenous ILK Enhances Cardioblast Formation
Whereas ILK gain-of-function increased the number of
cardioblast-containing aggregates, ILK-targeted siRNA caused a
reduction in endogenous ILK expression and a significant
decrease in cardioblast aggregate formation after 24 and 48 h
(Figure 2D). The reduction in ILK expression resulted in a parallel
reduction in the expression of the cardiomyocyte gap junction
protein C643 (Figure 2E). These results suggest that endogenous
ILK expression plays an important role in the promotion of
human fetal cardiomyogenesis.
Cardioblasts are Electrophysiologically Immature
Optical voltage mapping was performed to determine the
response of isolated cardioblast (in aggregates) to electrical field
stimulation. Only a small subset (,5%) of aggregates exhibited
electrical responses that were phase-locked to the stimulation train
(Figure 3A). Transfection of cells with either ad-GFP, ad-ILK
WT
or ad-ILK
R211A did not increase the fraction of aggregates
exhibiting electrical response. Although most cardioblasts express
b-MHC and the cardiomyocyte gap junction protein C643, only
ILK Induces Cardiomyogenesis
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protein cTnT (Figure 3B), reflecting the relative immaturity of
cardioblasts contained in the aggregates, and providing a possible
explanation for the electrically quiescent phenotype observed.
Characterization of ILK-induced Cardioblasts
Nk62.5 is the primordial homeodomain transcription factor
required for cardiac gene expression and is specifically essential for
left ventricular development [21]. To further characterize the
content of cell aggregates in response to ILK upregulation, we
probed our cell cultures with antibodies to the early cardiac
lineage marker nk62.5, the cardiomyocyte markers a-actin and
sarcomeric protein b-MHC and to a-SMA, a smooth muscle
actin-specific marker. We have established that aggregates induced
by ad-ILK
WT (Figure 4A) prevalently consisted of cells demon-
strating the presence of cardioblast marker nk62.5 and b-MHC.
The same cellular features were also observed in aggregates
induced by ad-ILK
R211A and even those sparse aggregates in ad-
GFP and non-infected control cells. EM of constituent cells
revealed sarcomeric structures of variable size and degrees of
organization (Figure 4B). These aggregates also contained
scattered endothelial cells and other a-SMA-negative cells that
did not display any GFP and thus were non ILK-transduced cells
(data not shown). The cardiomyogenic effects of ILK (WT and
R211A) were further evident by the increased expression of
cardiomyogenic transcription factors MEF-2C and GATA-4 as
determined by reverse transcriptase RT-PCR (Figure 4C).
ILK Co-localizes with Sarcomeric b-MHC
Confocal microscopy of primary cultures of fetal heart-derived
cells immunostained with anti-ß-MHC and anti-ILK antibodies
revealed that both detected antigens invariably overlap in the
cytoplasm of cells displaying different stages of cardiomyogenic
differentiation (Figure 5). In non-treated control cultures most of
the b-MHC-positive cells were early cardioblasts exhibiting
nascent sarcomeric structures. Only occasional cells represented
fully differentiated cardiomyocytes containing well-developed
striated sarcomeres. The co-localization of ILK with sarcomeric
b-MHC throughout progressive stages of human cardiomyocyte
differentiation implies a role for ILK in the morphogenesis of
functional sarcomeres.
Further analysis of cells transduced with ad-ILK
WT or ILK
R211A
showed that increased expression of ILK in ad-ILK
WT or ad-
ILK
R211A cultures coincided with a proportional increase in the
number of b-MHC-positive cells (WT, p,0.021; R211A,
p,0.001) (Figure 6A and 6B) and with the total amount of a-
and b-MHC protein detected by Western blot analysis (Figure 6C),
consistent with a dosage-dependent sarcomerogenic effect of ILK.
Overexpression of ILK Stimulates the Expression of Isl1 in
vitro and in vivo
The LIM-homeodomain transcription factor Isl1 demarcates a
distinct cardiac lineage referred to as the second heart field [22],
and has been implicated as part of an early transcriptional network
which commits a cardiac fate in mesodermal cells [23,24]. Loss-of-
function studies have confirmed the requirement for the expansion
and survival of Isl1 cardiac precursors in mouse embryonic and
human neonatal hearts in vivo [25,26].
While ILK treatment increases the number of cardioblasts in
vitro, it is remains unclear whether ILK specifies a cardiomyocyte
fate among uncommitted mesodermal cells, or whether it induces
proliferation of existing cardioblasts. To distinguish these possibil-
ities, Isl1 expression was determined using RT-PCR in both
adherent and non-adherent human fetal cellular fractions trans-
duced with ad-ILK
WT, ad-ILK
R211A and ad-GFP control. Results
of these experiments revealed the induction of Isl1 expression only
in ad-ILK
WT and ad-ILK
R211A cultures, but not GFP control-
treated cells (Figure 7A).
To confirm this finding in vivo we assayed the protein levels of
Isl1 by Western blot analysis of ventricular lysates from transgenic
mice with cardiac-restricted expression of constitutively active ILK
(ILK
S343D) or the PH domain mutant ILK (ILK
R211A) [4]. As
demonstrated in Figure 7B, the protein levels of Isl1 in ILK
R211A
transgenic mice were markedly higher than in littermate controls.
The expression levels of Isl1 in the ILK
S343D genotype were
undetectable by Western blot; however, RT-PCR analysis
revealed higher Isl1 mRNA expression in the hearts of ILK
S343D
than in littermate controls (Figure 7C). These results indicate that
the expression levels of ILK positively correlate with those of Isl1.
Since Isl1 is also expressed in cardiac progenitor cells (CPCs) [27],
we cannot exclude proliferation of CPCs or that of cardioblasts as
contributory mechanisms for the generation of the increased ILK-
induced Isl1 signal, and consequently, for the increased frequency
of cardioblast aggregates.
ILK Activates b-catenin in Human Fetal Cardiomyocytes
Upregulation of ILK leads to the activation and nuclear
translocation of b-catenin through inhibition of the b-catenin
phospho-degradation complex [28], which in turn, binds to
myogenic determination genes including b-MHC [29]. As shown
inFigure7Dtheexpressionlevelofthestabilized,dephosphorylated
form of ß-catenin was markedly increased in both, ad-ILK
WT- and
ad-ILK
R211A-transduced cultures, as compared to control ad-GFP
infected cells (p,0.001; ad-ILK
R211A or ad- ILK
WT vs. ad-GFP).
Increasedexpressionofactivatedß-cateninwasapparentinboththe
adherent and cardiomyocyte-enriched non-adherent cell fractions.
Since b-catenin is required for Isl1 expression in cardiac progenitor
cellsanddirectlyregulatestheIsl1promoter[25],ourresultssupport
a model in which ILK initiates the early cardioblastic commitment
of mesodermal precursor cells through a signaling pathway
minimally involving ILK, b-catenin and Isl1.
ILK is Expressed During Cardiogenesis in Human
Embryonic Stem Cells
Increasing expression of endogenous ILK level was also
confirmed during growth factor-induced early cardiogenesis using
Figure 1. Cellular phenotypes in primary cultures of human fetal myocardium. (A) Cells freshly isolated from 22 week fetal myocardium
were cultured for 2 days and then immunostained with anti-nk62.5 (red) and anti-vimentin (green) (top panel) or with anti a-actin (red) and anti ki-67
(green) (bottom panel) antibodies to determine the percentage of the cells with cardiomyocyte or fibroblast phenotypes. Nuclei were marked with
DAPI staining (blue). Scale bar, 30 mm. (B) Transmission electron microscopy showing that cultures of cells freshly isolated from human fetal
myocardium at day 2 contain primitive cardioblasts with nascent sarcomeres (s) and mitochondrial clusters (m) (left) and cells with the transitional
features containing both nascent sarcomeres and deep invaginations containing collagen fibers (cf) (right). (C) Only a subset of cardioblasts
expressed cardiac troponin T (cTnT). (D) Phase contrast images (upper panel) and fluorescent images (lower panel) showing the adherent (AC) and
non-adherent (NAC) cells 2 days after isolation. Immunostaining with anti-b-MHC antibody demonstrates that non-adherent clusters consist mainly of
b-MHC positive cardioblasts. Scale bar, 80 mm (for phase) and 25 mm (for fluorescent imaging).
doi:10.1371/journal.pone.0037802.g001
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Morphogenic Protein-4 in human embryonic stem cells (hESC)
(Figure 8) [30]. Here, ILK expression coincided with that of the
cardiac isoform of sarco(endo)plasmic reticulum calcium ATPase
(SERCA2a) and a-MHC, indicating that endogenous ILK is
upregulated during induction of the cardiomyogenic program in
hESCs.
Discussion
Data presented in this study indicate for the first time that
experimental overexpression of the multifunctional serine/threo-
nine kinase ILK promotes, in vitro, recruitment of human fetal
heart cells to a cardiomyogenic fate. ILK gain-of-function is shown
to induce the differentiation of a resident mesodermal precursor
cell toward an early cardiomyocyte characterized by nascent
sarcomeric structures, and to lead to subsequent cardiomyogenic
maturation through increased sarcomerogenesis. Proliferation and
cellular hypertrophy of existing cardioblasts have been inferred as
the mechanisms accounting for somatic growth of the fetal heart at
a stage after septation [31,32]. However, our finding that
accelerated cardiomyocyte specification is inducible by overex-
pression of ILK at a stage subsequent to definitive ventricular
chamber formation suggests the persistence of a recruitable
precursor cell population late in human cardiac development.
Further studies are required to identify the specific precursor cells
that give rise to cardioblasts in response to ILK overexpression. In
further support of the cardiomyogenic role of endogenous ILK, we
demonstrate that targeted reduction of ILK expression using
siRNA led to a reduction in cardioblast formation. Our studies
also demonstrate that expression of endogenous ILK progressively
increases during growth factor-induced early cardiogenesis in
hESCs. Support for a critical role of ILK in the initiation and
maintenance of the normal cardiomyogenic phenotype is also
found in previous studies showing that disruption of ILK signaling
during development leads to neonatal cardiomyopathy [9,10].
Most studies of the signaling pathways during heart develop-
ment concern those regulating secondary heart field (SHF)
development, which forms the definitive outflow tract, including
those regulated by Wnt, fibroblast growth factor, bone morpho-
genetic protein, Hedgehog, and retinoic acid signaling (reviewed in
[33], whereas more limited data is available concerning pathways
responsible for the primary or first heart field (FHF), which
comprises the dominant portion of the left ventricle. The results of
our study of ILK-induced cardiomyogenesis implicate a more
global role for b-catenin activation in ventricular morphogenesis,
and are consistent with previously published results showing that
activation of Wnt/b-catenin pathway enhances embryonic stem
cell differentiation into cardiomyocytes [17], accelerates cardio-
genesis in the undifferentiated P19CL6 cell line [34], and
promotes the expansion of cardiac progenitor cells and is required
for cardiac differentiation [35].
Other studies indicate more complex context-specific and
antagonistic effects of Wnt signaling on cardiomyogensis [14,17].
ILK can also signal through a c-Jun-N-terminal kinase (JNK/c-
Jun) signaling axis independently of the canonical signaling target
GSK-3b [36]. Since non-canonical Wnt signaling via Wnt11 is
sufficient to induce cardiomyogenesis in bone marrow mononu-
clear cells in a JNK/c-Jun-dependent manner [37], the myogenic
effects of ILK may depend upon the contextual balance of
canonical and non-canonical Wnt signaling. It was previously
shown that ILK elevates the protein translation mediator P70S6
kinase (p70S6K) during cardiac hypertrophy [4], and indepen-
dently that p70S6K induces differentiation in human embryonic
stem cells [38]. The precise molecular mechanism of the effect of
ILK overexpression on induction of cardioblast in human fetal
heart remains to be determined.
Cardioblasts generated by ILK overexpression displayed low-
level organization of sacromeric structures and were nk62.5-
positive indicative of a cardiomyogenic lineage. Interestingly, a
population of early presumptive cardioblasts in the adherent
fraction displayed coexistence of intracellular collagen fibrils and
early sarcomeres, possibly indicating their origin from progenitors
with both fibroblastic and cardiomyogenic potential. Cells
exhibiting progressively more distinct striations typical of more
differentiated cardiomyocytes were mostly present in non-adher-
ent aggregates and stained positively predominantly for b-MHC
representing the fetal isoform of sarcomeric protein. Moreover,
confocal microscopy revealed localization of ILK to sarcomeres
suggesting a possible role for ILK in nucleating new sarcomeres,
and providing a basis for the pro-hypertrophic effects observed
with ILK activation [4,6]. Co-localization of ILK and sarcomeres
was also previously reported in fully differentiated cardiomyocytes
in zebrafish [9].
ILK overexpression was shown here to increase the expression
of the early marker of cardiogenesis, Isl1, in human cardiac cells in
vitro and in the ILK transgenic mouse lines. Previous studies have
suggested that Isl1 may also be expressed in FHF and thus
represent a pan-cardiocytic marker for both myocardial cell
lineages [27,33] and may account for the finding herein of ILK-
induced Isl1 expression in human fetal cardiac cells that are
assumed to derive predominantly from the FHF-derived ventric-
ular mass. Our previous study demonstrated an increase in the c-
Kit progenitor cell compartment in ILK-treated human fetal cell-
derived cultures [39]. The current study does not address the
nature of specific cardiac precursor cells that are responsive to ILK
induction, which is better approached by examination of the
effects of defined factors on cellular phenotypes present at pre-
cardiomyogenic stages using a hESC platform [30]. A recent
advance toward this objective was the identification of signal
regulatory protein alpha (SIRPA) as a cardiomyocyte-specific
marker that distinguishes the cardiomyogenic lineage from
nonmyocyte precursor cells among populations of human induced
pluripotent stem cells and hESCs [40].
Figure 2. Over-expression of ILK induces robust cellular aggregation. (A) Fluorescent microscopy images and their composites with the
phase contrast images identify the cells transduced with GFP-linked vectors (ad-GFP), wild type ILK vector (ad-ILK
WT) and mutant ILK vector (ad-
ILK
R211A). Scale bar, 80 mm. (B) Quantification of cell aggregates in AC (right panel) and NAC (left panel) infected with ad-ILK
WT, ad-ILK
R211A, ad-GFP
and non-infected cells. Bar graphs represent mean values 6SD, n=10 (random fields), *p,0.02, **p,0.02, ***p,0.03 (for AC) and *p,0.001,
**p,0.0001, ***p,0.001 (for NAC). Note that ad-ILKWT and ad-ILKR211A are significantly different from ad-GFP and that ad-ILKR211A is significant
different from ad-ILKWT. (C) Western-blot analysis demonstrates a progressive increase in the level of ILK expression in AC and NAC transduced with
ad-ILK
WT, ad-ILK
R211A as compared to non-transduced cells and cells transduced with the vector bearing the GFP-encoding message only. GAPDH was
used as a loading control. (D) The number of aggregates was enumerated in human fetal cardiac cells cultures treated with ILK siRNA or scrambled
siRNA. 2-tailed p,0.05 at 24 (*) and 48 (**) hours post-transduction. (E) ILK (WT and R211A) overexpression increases the coexpression of ILK and
C643 (left panel); ILK siRNA reduces the endogenous expression levels of these proteins (right panel).
doi:10.1371/journal.pone.0037802.g002
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PLoS ONE | www.plosone.org 6 May 2012 | Volume 7 | Issue 5 | e37802Figure 3. Response of cardioblast aggregates to electrical stimulation. (A) Upper panel shows electrical activity elicited by an increasing rate
field electrical stimulation. Lower panel shows another aggregate subject to a constant-rate electrical stimulation. Optical voltage mapping was
performed using fluorophore DI-4-ANEPPS as described in Methods. (B) Cells were stained with flouresence-labelled antibodies to b-MHC, C643 and
cTNT. Scale bar, 30 mm.
doi:10.1371/journal.pone.0037802.g003
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PLoS ONE | www.plosone.org 8 May 2012 | Volume 7 | Issue 5 | e37802The majority of cardioblasts examined in our study were not
spontaneously contractile, and only a small subset was responsive
to electrical stimulation. Previous reports describing a higher
proportion of contractile cells were based on subcloning methods
to isolate CPCs, which then underwent spontaneous or directed
cardiomyogenic differentiation [41,42]. Our studies, in contrast,
investigated the phenotype of unselected populations of cells that
were not enriched for progenitor cells and contained cardiomy-
ocytes reflecting the spectrum of differentiation likely to be present
in vivo. The relative electrical quiescence of freshly isolated human
Figure 4. Cellular aggregates in ILK over-expressing cultures are mostly comprised by cardiooblasts. (A) Immunocytochemistry
indicates that cellular aggregates present in the ILK
WT -transduced cultures contain numerous cardioblasts displaying the presence of a-actin, b-MHC
and nk62.5 (all marked with red rhodamine). Nuclei were identified with blue DAPI and expression of ILK was marked with green GFP. In top and
middle panels, scale bars represent 80 mm; in the bottom panel, scale bar represents 25 mm. (B) Transmission electron microscopy showing clusters of
mitochondria (m) in the cytoplasm of the primitive cardioblast (left). The more differentiated cells (right panel) contained similar mitochondrial
clusters located in close proximity to the nascent sarcomeres (s). (C) Cardioblasts transduced with ILK (WT and R211A) and control vector were
analyzed by RT-PCR for expression of cTNT, GATA-4 and MEF-2c transcripts.
doi:10.1371/journal.pone.0037802.g004
Figure 5. ILK co-localizes with b-MHC in sarcomeres of fetal cardiac cells. Immunocytochemistry of primary cultures of fetal myocardium-
derived cells indicates that ILK expression is present in cells representing all stages of cardioblastic-cardiomyogenic differentiation. Confocal
microscopy showing human fetal heart derived cells (22 weeks gestation) cultured for 2 days and immunostained with anti-b-MHC (MF-20) (red) and
anti-ILK (green) antibodies. Nuclei were detected with DAPI staining (blue). Scale bar, 10 mm.
doi:10.1371/journal.pone.0037802.g005
ILK Induces Cardiomyogenesis
PLoS ONE | www.plosone.org 9 May 2012 | Volume 7 | Issue 5 | e37802Figure 6. Over-expression of ILK in human fetal cardiac cells induces production of b-MHC. (A) Immunofluorescent staining for b-MHC
(red) in human fetal heart-derived cells (21 weeks gestation) infected with adenovirus encoding ad-ILK
WT, ad-ILK
R211A and ad-GFP. Nuclei were
detected with DAPI staining (blue). Scale bar, 30 mm. (B) Quantification of the number of b-MHC positive cells detected by immunostaining in
adherent fetal cardiomyocytes infected with adenovirus encoding ad-ILK
WT, ad-ILK
R211A and ad-GFP. Bar graphs represent mean values 6 SD, n=14
(random fields), *p,0.02, **p,0.001, ***p,0.03. (C) Western Blot analysis for ILK, cardiac specific a-MHC and b-MHC expression levels in adherent
(AC) and non-adherent (NAC) fetal cardiac fractions infected with ad-ILK
WT, ad-ILK
R211A and ad-GFP. Each experiment was performed at least three
times on independent samples and one representative blot is shown.
doi:10.1371/journal.pone.0037802.g006
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PLoS ONE | www.plosone.org 11 May 2012 | Volume 7 | Issue 5 | e37802fetal and adult cardiac cells has led to the use of iPSC [43] - and
hESC [30] -derived cardiogenesis as more robust models to
investigate the electrophysiological properties of human cardio-
myocytes.
Altogether, our results identify ILK as a novel regulator in the
induction of cardiomyogenic fate. Remarkably, ILK may serve a
dual function, regulation of sequential phases of cardiomyogenesis,
and, as a mechanoreceptor protein, stress-dependent modulation
of cardiomyocyte contractility throughout postnatal life [4,5].
These diversified functions of ILK are unified by the process of
sarcomeric morphogenesis which is responsive to mechanical stress
during development and during dynamic mechanical loading
postnatally. The multifunctional properties of ILK contrast with
that of orthodox cardiomyogenic transcription factors, such as Isl1
and nk62.5, which are activated transiently during cardiogenesis.
The positioning of ILK as a single upstream node but with both
structural and signal transduction properties leveraged by exten-
sive protein-protein interactions [5,44], represents an efficient
molecular mechanism to orchestrate multiple aspects of cardio-
myocyte development and function.
Interestingly, overpression of the activation resistant ILK
R211A mutant resulted in much greater increase in the number
of new cell aggregates as compared to overexpression of wild-type
ILKWT. The potency of the cardiomyogenic effects of the ILK
R211A mutation are consistent with a model in which ILK (WT
and R211A) exogenously delivered to the cell bypasses the
requirement for proximal PI3K-dependent activation. The ILK
R211A mutation possesses a normal kinase domain and thus
retains signaling competence, and exhibits high expression levels,
and these factors may account for its cardiomyogenic potency.
This feature may have translational significance since the R211A
mutation appears to be phenotypically inert and thus potentially
less oncogenic [45] than other prosurvival molecules or stem cell
based approaches.
Since ILK is known to be activated by hypoxia, which normally
occurs during fetal heart development [46] and in postnatal heart
disease [4], these findings support the paradigm that stress
induction of ILK might serve as a novel endogenous regulator
of cardiomyogenesis. The identification of ILK as a nodal
regulatory element during cardiomyogenesis increases the scope
of potential translational approaches designed to exploit this
pathway. Furthermore, our data encourages future studies aimed
at controlled activation of ILK pathway that may be useful in
promoting the cardiomyogenic differentiation of induced plurip-
otent stem cells, and may eventually lead to the development of
novel therapeutic approaches allowing regeneration of diseased
human myocardium.
Material and Methods
Cell Isolation and Culture
Human fetal hearts were harvested following elective pregnancy
termination at 19 to 22 weeks gestation. Approval by the Human
Research Ethics Board of the Hospital for Sick Children and
written maternal consent were obtained for this study. The hearts
were minced and washed with phosphate-buffered saline. Cells
isolation was performed with 0.2% trypsin and 1 mg/ml type II
collagenase in 0.02% glucose phosphate-buffered saline (PBS),
pH7.4 solution at 37uC. After dissection, cells were incubated on
plastic culture dishes (Sarstedt, Inc, Newton, NC) for 2 hours at
37uC to separate cells for adherent and non-adherent cells, with
Iscove’s modified Dulbecco’s medium (IMDM, Gibco, Invitrogen
Corporation, Carlsbad, Calif) containing penicillin and strepto-
mycin and supplemented with 10% fetal bovine serum (FBS,
Gibco). After incubation, the supernatant with non-adherent cells
was transferred to new culture dishes (Sarstedt). Both adherent and
non-adherent cells were placed in a 5% carbon dioxide incubator
at 37uC prior to infection.
In vitro Studies Using ILK Adenoviral Infection
Cells were cultured to 60%–70% confluency prior to
adenovirally mediated infection with serotype 5 adenovirus
encoding either human wild-type ILK gene (ad-ILK
WT)o ra
mutant ILK gene (ad-ILK
R211A) in a bicistronic construct
containing GFP as a reporter gene [4]. Control cultured cells
were infected with adenovirus containing the reporter gene alone
(ad-GFP). Cells were infected at 37uC at multiplicity of infection
of 1.5 in IMDM media supplemented with 10% FBS for 24
Figure 7. Over-expression of ILK induces Isl1 expression and b-catenin stabilization in vitro and in vivo. (A) Semi-quantitative RT-PCR
analysis showing the Isl1 expression in adherent (AC) and non-adherent (NAC) cells derived from fetal myocardium transduced with ad-ILK
WT, ad-
ILK
R211A or ad-GFP. GAPDH expression was also tested in all experimental groups. (B) Western Blot analysis of protein levels of ILK and Isl1 in
myocardial lysates derived from transgenic mice with cardiac-restricted expression of constitutively active ILK (Tg
S343D) or mutant ILK (Tg
R211A) and
their littermate controls. (C) Semi-quantitative RT-PCR analysis demonstrating the Isl1 expression in hearts of transgenic mice with cardiac-restricted
expression of constitutively active ILK (Tg
S343D)( +) compared to their littermate controls (2). (D) Western blot analysis showing the protein levels of
stabilized, dephosphorylated b-catenin and total amount of b-catenin in adherent and non adherent fetal cardiac fractions infected with ad-ILK
WT, ad-
ILK
R211A or ad-GFP. Each experiment was performed at least three times on independent samples and one representative blot with its corresponding
expression ratios (active/total b-catenin expression) is shown at the top. The bar graph at the bottom summarizes the quantitative analysis of
stabilized b-catenin expression in cells derived from fetal myocardium transduced with ad-ILK
WT, ad-ILK
R211A or ad-GFP. Data are mean 6 SD,
*p,0.007, **p,0.001, ***p,0.05.
doi:10.1371/journal.pone.0037802.g007
Figure 8. Endogenous ILK is expressed during human embry-
onic stem cell (hESC) cardiogenesis. The induction of ILK is
coincident with increasing expression of cardiomyocyte-specific sarco-
plasmic endoplasmic reticulum calcium ATPase, isoform 2a (SERCA2a)
and a-MHC. T0220 marks the time in days during differentiation of cells
from embryoid bodies to cardiomyocytes.
doi:10.1371/journal.pone.0037802.g008
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efficiency was confirmed by the expression of GFP.
Western Blots
For western blot analysis, total and phospho-specific protein
expression was measured in lysates derived from human fetal
cardiomyocytes in culture and from transgenic and control mouse
ventricular tissue as described previously [4]. Briefly, cells extracts
were prepared by lysing cells for 20 min on ice in RIPA lysis buffer
(150 mM NaCl, 1% Nonidet P40, 05% deoxycholate, 0.1% SDS,
50 mM Tris, pH 8.0, and 1 mM PMSF). The expression levels of
proteins was assessed using the following primary antibodies:
rabbit monoclonal anti-ILK (Clone 4G9, Cell Signaling Technol-
ogies), rabbit polyclonal anti-Isl1 (Chemicon International, Inc),
mouse monoclonal anti-b-catenin (Clone E-5, Santa Cruz
Biotechnology, Inc), mouse monoclonal anti-active-b-catenin
(Clone 8E7, Millipore), monoclonal anti-GAPDH (Clone
GAPDH-71.1, Sigma), mouse monoclonal anti-myosin heavy
chain-b (Clone A4.951, Santa Cruz Biotechnology, Inc), rabbit
polyclonal anti-a myosin heavy chain (Sigma). After incubation
with the primary antibody, the blots were washed and incubated
for 1 h with the appropriate horseradish peroxidase-conjugated
secondary antibody (Jackson ImmunoResearch Laboratories).
Proteins were visualized with an enhanced chemiluminescence
(ECL) detection reagent (Amersham Pharmacia Biotech) and
quantified by densitometry.
Immunohistochemical Analysis
Cultured cells on coverslips were maintained in culture for 4–7
days and then fixed with 4% paraformaldehyde for 20 min at
room temperature. Following rinsing with PBS, cells were
permeabilized with 0.1% Triton-X 100 (Sigma) for 10 min and
then blocked with normal goat serum or 5% milk for 30 min and
subjected to immunostaining. The following primary antibodies
were used in this study: rabbit polyclonal anti-vimentin (Abcam
Inc), rabbit monoclonal anti-ILK (Clone 4G9, Cell Signaling
Technologies), mouse monoclonal anti myosin heavy chain-b
(Clone MF-20, provided by Dr. Donald A. Fischman, Cornell
University Medical College, NY), mouse monoclonal anti-nk62.5
(Clone 259416, R&D Systems), mouse monoclonal anti a-actin
(Clone 1A4, Santa Cruz Biotechnology, Inc), rabbit polyclonal
anti-ki-67 (Millipore), mouse monoclonal anti cardiac Troponin T
(Clone 13–11, Thermo Fisher Scientific), rabbit polyclonal anti-
connexin 43 (Sigma). Nuclei were stained with 4,6-diamino-2-
phenylindole (DAPI). All analysis was done with OpenLab 4.0.2
software (Agilent Technologies, Scientific Software Inc, Palo Alto,
Ca.).
Semi-quantitative Reverse Transcription (RT–PCR)
Total RNA from cultured cells or heart tissue was prepared by
using TRIzolH (Invitrogen) according to the manufacturer’s
instructions. Total RNA (1 mg) was reverse-transcribed with the
SuperScript First-strand Synthesis System (Invitrogen). The cDNA
of targeted genes was then amplified using the following primers:
mouse Isl1:5 9-CGTGCAGACCACGATGTGG-39 and 59-
GACTGAGGCCCGTCATCTC-39; human Isl1:5 9- CACGAT-
CAGTATATTCTGAG-39 and 59-CGTGGTCTGCTCGGCA-
GAAG-39; human cTnT: 59 –ATGAGCGGGAGAAG-
GAGCGG CAGAAC-39 and 59 -
TCAATGGCCAGCACCTTCCTCCTCTC-39; human MEF-
2c: 59 –TTTA ACACCGCCAGCGCTCTTCACCTTG-39 and
59 –TCGTGGCGCGTGTGTTGTGGGTATCT CG-39; hu-
man GATA-4: 59 –GCTCGTGCGCCACCTCCAGGC-39 and
59 –GGCAAC AACGA TAATATGCG-39. A total of 30
amplification cycles were performed. To control for the amount
of intact RNA, GAPDH was amplified in parallel with the
following primers: mouse GAPDH: 59-AGGGCTGCCATTTG-
CAGTGG-39 and 59- CATTTGATGTTAGTGGGGTCT -39;
and human GAPDH: 59- CGGATTTGGTCGTATTGGGC-39
and 59- CTCCATGGTGGTGAAG ACG-39.
RNA Interference, Transfection, and Transduction
siRNA against ILK (siILK) and negative control siRNA were
purchased from Cell Signaling Technologies. Cells were trans-
fected with siRNAs (130 mM final concentration) using the X-
tremeGENE siRNA transfection reagent (Roche Diagnostics,
Laval, QC, Canada) according to the manufacturer’s instructions.
To induce transduction efficiency the cells were transfected again
after 24 hours with the same concentration of siRNA. The cells
were analysed after 48 h post-transfection.
Transmission Electron Microscopy (EM)
For electron microscopic analysis, cells were fixed for 10 min in
1% glutaraldehyde 4% formaldehyde mixture in PBS, scraped off
and pelleted. Fixation was continued for 1 h. After fixation, the
cells were post-fixed in 1% solution of osmium tetroxide and
dehydrated in graded acetone at 4uC. After embedding and
polymerization, 0.5-mm-thick sections were initially cut with a
Leica Ultracut UCT ultramicrotome, stained in uranyl acetate and
lead citrate, and observed with transmission electron microscopy
at 80 kV using a Philips CM100 transmission electron microscope.
Generation of Transgenic Mouse Lines
The methods for generation of transgenic animals conveying
cardiac-specific over-expression of human ILK gene containing a
PH-domain (ILK
R211A) and constitutive-active (ILK
S343D) muta-
tion have been previously described [4].
Generation of Human Embryonic Stem Cells
hESCs were maintained in defined culture and differentiated
into cardiomyocytes using stage-specific exposure to nodal, activin
and BMP, as described [30].
Electrical Responsiveness of Human Fetal
Cardiomyocytes
Optical voltage mapping was performed using fluorophore DI-
4-ANEPPS. The cell cultures were incubated with 5 uM DI-4-
ANEPPS for 20 minutes. Optical mapping was performed using a
high-speed camera (SciMedia USA) equipped with a 1006100
pixel CMOS sensor. The fluorescence was excited using a 150 W
halogen lamp (Moritek Corp Japan) with a 530 nm bandpass filter
and was measured using a microscope and a 610 nm long pass
filter (THT, SciMedia USA) which provided a 5 mm65 mm field
of view.
Statistical Analysis
Statistical comparison of ILK-specific effects relied on a paired t
test or analysis of variance (ANOVA) followed by the multiple-
comparison Bonferroni t test to assess differences among groups.
The significance level was set at p,0.05.
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